HomeAbout

TL;DR CNBC


Britain tries to cool AstraZeneca concerns as its CEO touts a new vaccine trial - TL;DR CNBC

Britain tries to cool AstraZeneca concerns as its CEO touts a new vaccine trial

Publishing timestamp: 2020-11-27 09:52:24


Summary


Sentiment: NEGATIVE

Tickers: AZN-GB

Keywords:

Source: https://www.cnbc.com/2020/11/27/britain-tries-to-cool-astrazeneca-concerns-ceo-touts-new-vaccine-trial.html


Developed by Leo Phan